Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
11 déc. 2024 11h39 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Bone Marrow Aspirate Concentrates - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Bone...
Stem Cell Therapy Market Is Expected To Reach Revenue Of USD 54.7 Bn By 2033, At 12.6% CAGR: Dimension Market Research
11 déc. 2024 09h08 HE
|
Dimension Market Research
New York, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Overview The Global Stem Cell Therapy Market is projected to reach USD 18.9 billion in 2024 which is further anticipated to reach USD 54.7 billion by...
Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
02 déc. 2024 09h05 HE
|
Longeveron
Longeveron will participate in the Emerging Growth Virtual Conference with company presentation December 5th at 12:00pm ET.
Stem Cell Therapy Strategic Business Report 2024 - Allogeneic Stem Cell Therapy Segment is Expected to Reach US$1 Billion by 2030 with a CAGR of a 16.7%
02 déc. 2024 04h23 HE
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell Therapy was...
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
12 nov. 2024 16h05 HE
|
Longeveron
Longeveron reports 3Q24 financial results. Pivotal Phase 2b clinical trial in HLHS achieves 80% enrollment. Positive Phase 2 data for Alzheimer's disease.
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)
11 nov. 2024 09h05 HE
|
Longeveron
Longeveron has appointed Devin Blass as Chief Technology Officer (CTO) and SVP of CMC, effective Dec 2, adding capabilities ahead of potential BLA filing.
Stem Cell Therapy Market Analysis Report 2024-2029: iPSC Technology and Personalized Medicine Trends Drive Growth
06 nov. 2024 05h12 HE
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market: Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has...
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
04 nov. 2024 16h05 HE
|
Longeveron
Longveron will report third quarter 2024 financial results and provide a business update on Tuesday, November 12th after the U.S. financial markets close.
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
29 oct. 2024 10h00 HE
|
Longeveron
Longeveron presents clinical data for stem cell therapy in Alzheimer's disease. Findings offer potential mechanistic and clinical insights.
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
29 oct. 2024 09h00 HE
|
Regenerative Medical Solutions
Boston, MA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October 28-29 at the Joseph B....